|
11 Sep 2025 |
SBI Life Insurance
|
Consensus Share Price Target
|
1833.70 |
2082.42 |
- |
13.56 |
buy
|
|
|
|
|
27 Apr 2023
|
SBI Life Insurance
|
SMC online
|
1833.70
|
|
1137.05
(61.27%)
|
|
Results Update
|
|
|
|
|
27 Apr 2023
|
SBI Life Insurance
|
BOB Capital Markets Ltd.
|
1833.70
|
1520.00
|
1137.05
(61.27%)
|
Target met |
Buy
|
|
|
Strong performance in FY23 with gross premium up 15% YoY and APE growth of 18%
|
|
27 Apr 2023
|
SBI Life Insurance
|
ICICI Securities Limited
|
1833.70
|
1650.00
|
1137.05
(61.27%)
|
|
Buy
|
|
|
SBI Life (SBLI) reported strong APE/VNB growth of 18%/37% in FY23. Company maintains its strong outlook of >20% growth in APE in FY24. SBLI is relatively unaffected by the new tax regulations due to its low share of >Rs500k ticket-size policies (less than 2% of total APE in 9MFY23) and has been better than peers in terms of growth in the number of policies (14% YoY growth in FY23 and 12% CAGR between FY20-23).
|
|
27 Apr 2023
|
SBI Life Insurance
|
ICICI Direct
|
1833.70
|
1350.00
|
1137.05
(61.27%)
|
Target met |
Buy
|
|
|
|
|
27 Apr 2023
|
SBI Life Insurance
|
Motilal Oswal
|
1833.70
|
1500.00
|
1137.05
(61.27%)
|
Target met |
Buy
|
|
|
|
|
07 Feb 2023
|
SBI Life Insurance
|
Geojit BNP Paribas
|
1833.70
|
1218.00
|
1131.75
(62.02%)
|
Target met |
Hold
|
|
|
|
|
23 Jan 2023
|
SBI Life Insurance
|
Axis Direct
|
1833.70
|
1565.00
|
1295.40
(41.55%)
|
|
Buy
|
|
|
We maintain our BUY recommendation on the stock.
|
|
23 Jan 2023
|
SBI Life Insurance
|
BOB Capital Markets Ltd.
|
1833.70
|
1611.00
|
1295.40
(41.55%)
|
|
Buy
|
|
|
Strong 15% YoY growth in 9M gross premium with an in-line Q3; APE clocks robust 20% increase
|
|
23 Jan 2023
|
SBI Life Insurance
|
SMC online
|
1833.70
|
|
1295.40
(41.55%)
|
|
Results Update
|
|
|
|
|
23 Jan 2023
|
SBI Life Insurance
|
ICICI Securities Limited
|
1833.70
|
1600.00
|
1296.10
(41.48%)
|
|
Buy
|
|
|
SBI Life Insurance Company (SBI Life) reported strong 9MFY23 performance with APE growth of 20% YoY, VNB growth of 44% YoY and VNB margin at 29.6% YoY. While there has been a sequential decline of 400bps in Q3FY23 margin due to increase in ULIP mix, we expect the overall business momentum to continue and result in a healthy core RoEV of more than 20% in FY23E/FY24E.
|